No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
about
Sustaining attention to simple tasks: a meta-analytic review of the neural mechanisms of vigilant attentionModifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression.Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?Relationship between ecstasy use and depression: a study controlling for poly-drug use.Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.Ecstasy intoxication: the toxicological basis for treatment.Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.The P3 in 'ecstasy' polydrug users during response inhibition and execution.Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.Modelling the adverse effects associated with ecstasy use.Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.
P2860
Q28708997-5F7B6B80-DE42-4CC2-A590-B39AA708831DQ33624984-6B20CC51-449D-4C46-AD17-859E83A7599FQ34982523-8EDF6C6C-A2BD-49D8-B0C8-1A8F645E8B15Q35010538-AD331EE8-4E9E-4D09-BB22-4E5FF4CD1933Q36410784-DB800BB5-BD8A-4F7D-8971-85A729B749B4Q36679249-46B9FAB8-4FDD-4803-81BD-6326110014F1Q36803318-9B46052B-33DF-4F92-B205-2E45E14B64EAQ36831009-A2EF3BAC-8F41-44E4-B67D-8007D8C1E751Q36914695-C0F29723-5885-4828-90B6-4C95CFAB251CQ40346595-C56B8EC1-5A33-4F2E-BA97-511A882CD4C3Q40540791-9D5A54F5-1AF0-4EAF-A1FF-8FCAE11470F8Q44252300-6838F86B-4B65-4927-9748-429A9DEEDD51Q46046635-AB9391F6-0C33-43AA-B072-0F67AE5FDFE1Q46705993-407CCDF0-5C73-4877-8BCB-F3BC9944051EQ46726341-6669B510-D4EA-4D8B-850E-642BBC67FABDQ46970793-16E002AA-9F08-4DF0-B115-B84A4DC7ACC4Q48325721-ADA34100-1FBD-42AF-BA22-A1ACA847C314Q51919664-C5800616-8571-4E11-95A0-60E264EFFAA9Q54297002-56158FE5-8763-4DAF-BC5D-0B2ECA35E7AB
P2860
No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
No difference in brain activat ...... ron emission tomography study.
@ast
No difference in brain activat ...... ron emission tomography study.
@en
type
label
No difference in brain activat ...... ron emission tomography study.
@ast
No difference in brain activat ...... ron emission tomography study.
@en
prefLabel
No difference in brain activat ...... ron emission tomography study.
@ast
No difference in brain activat ...... ron emission tomography study.
@en
P2093
P1476
No difference in brain activat ...... ron emission tomography study.
@en
P2093
P356
10.1097/00004714-200102000-00012
P407
P577
2001-02-01T00:00:00Z